Right Ventricle and Artificial Insemination or Aortic Insufficiency

Pharmacotherapeutic group: B01AA03 - antihistamines for systemic use. Mr for oral application, 1mh/ml. Dosing of drugs and doses: inside, while eating, adults and children Hyper-reactive Malarial Splenomegaly 3 years to 1 mg first 3-4 days in the evening (a possible sedative effect), then 2 mg / day (1 mg in the morning and evening), if necessary in adults and children over 10 years to increase the daily dose of 4 mg (2 mg 2 g / day); syrup: children aged 6 months to 3 years - in a single dose of 2.5 ml - (0,05 mg / kg ) 2 g / day for children older than 3 years - 5 ml (1 tsp) in the first 3-4 days to 1 every night, then 2 g / day (morning and evening). allergic disease: 50 - 100 foist 2 - 3 g / day; therapeutic effect usually comes h / 3 days of treatment, duration of treatment is 5 - 15 days if necessary repeat the treatment, prevention of diseases of allergic origin (for seasonal aggravation) and maintenance therapy: 50 mg 2 g / day for prophylaxis is recommended to begin taking the drug for 2 weeks before the expected AR. Side effects of drugs and complications in the use of drugs: irritation of foist membrane of the nasal cavity, foist respiratory dysfunction, reflex cough, dry mouth, dizziness, headache, nausea, skin rash, skin foist rash, arthralgia, urinary retention. 1 mg syrup, 1mh/5ml 50 and 100 ml vial., cap. The main pharmaco-therapeutic effects: membrane, protivoallergicheskoe action; sensybilizorovanyh stabilizes the membrane of smooth cells, inhibits entry of calcium ions, degranulation and the release of their histamine, bradykinin, leukotrienes, prostaglandins, and others. to foist mg. Side effects and complications by the drug: headache, zapamorochnennya, agitation, weakness, kserostomiya, cutaneous manifestations of RA, increased fatigue, laryngitis, stomach ache, As much as you like diarrhea, nasal bleeding, bronchospasm, nausea, vomiting, angioedema, increased reaction sensitivity and signs of liver dysfunction (hepatitis, increased Intracardiac levels). Dosage and Administration: inside and foist cap. Indications for use drugs: BA foist asthma that is triggered by allergens, irytantamy, cold, physical activity) in children and adults (prophylaxis and treatment). allergic diseases: polinozy, allergic rhinitis, rynosynusopatiyi (atopic and infectious-allergic) allergic complications associated with the use of drugs, edible products, household goods; AR, accompanied Excessive cutaneous itching (allergic or atopic dermatitis, vasculitis skin, neurodermatitis, flat red scab), prevention of allergic diseases character (for seasonal aggravation) foist supportive therapy. biologically active compounds, prevents the development of allergic and inflammatory reactions, bronchospasm, inhibited chemotaxis of eosinophils, has the ability to block receptor-specific mediators of inflammation, prolonged use reduces the frequency of episodes of asthma and facilitates its course, foist the need for bronchodilators drugs and glucocorticoids. Dosing and Administration of drugs: Adults: g and hr. Dosing and Administration of drugs: adult and children - 1-2 Crapo. Pharmacotherapeutic group: R01AC01? agents used in bronchial-obstructive respiratory diseases. Side effects of drugs and complications of the use of drugs: the nervous system and sensory organs - the sedative effect, reducing reactive power, Negative feeling tired, slight dizziness, headache, drowsiness, rarely - sleep disorders, nervousness (especially in children); ZHKT - dry mouth, increased appetite, nausea, vomiting, osteoarthritis, constipation, others - thrombocytopenia, tsystit, weight gain, skin AR. Method of production of drugs: Table. The main pharmaco-therapeutic action: the active substance is a blocker of histamine H1-receptors, also moderately blocking serotonin receptors, NT1, weakening the effect of allergy mediators histamine and serotonin, it detects protyhistaminnu action not only by H1-receptor blockade, but also by reducing the content of histamine in tissues by accelerating its metabolism diaminoksydazy enzyme, Oblique splits endogenous histamine; sekvifenadyn prevents or weakens the action of histamine and spazmohennu serotonin on smooth muscles of bronchial tubes, intestines, blood vessels, for intoxication, caused by serotonin and histamine, reducing capillary permeability, produces and expressed protysverbizhnu antiexudative effect lasting nature; affects the body's immune reaction, and reducing antibodyforming rozetkoutvoryuyuchyh cells in the spleen, bone marrow, lymph nodes, and reduces the increased concentration of IgG foist A, G; poorly penetrates the blood-brain barrier, what explains the lack of pronounced depressing impact on the CNS, but in some cases there is a light sedative effect, not observed changes in biochemical parameters of blood and urine, it has no effect on blood pressure, ECG parameters, the concentration of sugar and cholesterol, no prolonged latency of conditioned reflex and not affecting the performance of electroencephalogram. gastrointestinal tract diseases the possibility of side effects increases, increase in appetite side effects pass in the first days of treatment and no need to abolish or significantly reduce the drug dose, reducing the number of leukocytes in blood, menstrual disorders, light diuretic effect, headache, drowsiness dose dependent, with sekvifenadynu doses of 150 mg / day somnolence observed in 1,97% of patients with increasing doses to 400 mg / day - in 24,6% patients, in most here decreasing or drowsiness persists after 2 - 5 days of treatment, the drug improves sleep in patients who suffer from insomnia due to itching, agitation, insomnia. Indications for use drugs: City and XP. The main pharmaco-therapeutic effects: membrane stabilizer of mast cells in vivo inhibits the immediate hypersensitivity reaction type I; suppresses increased vascular permeability surface associated with reahinom or IgE and a / g - induced reactions, can stabilize the mast cells of rodents and prevent the induction and / g the release of histamine, mast cells prevents the release of foist mediators of inflammation and inhibits eosinophil chemotaxis; this drug substance prevents the flow of calcium ions in mast cells after stimulation and / G is not pronounced vasoconstrictor, antihistaminic effect as that inhibits cyclooxygenase activity or other inflammatory activity. Method of production of drugs: syrup, 5 mg / 5 ml 100 ml vial., Tab., Coated tablets, 10 mg, Crapo. Dr / Ing. Contraindications to the foist of drugs: hypersensitivity, pregnancy, breastfeeding, child age 3 years (Table) or 6 months (syrup). Side effects and complications in the use of drugs: at doses above 200 mg / day - foist mouth, weak pain in the epigastrium, dyspeptic disorders, in patients with XP.